Appointments to the Clinical Advisory Board

RNS Number : 7342T
Surgical Innovations Group PLC
18 December 2012



Surgical Innovations Group plc

("SI" or the "Company")


Appointments to the Clinical Advisory Board


Surgical Innovations Group plc (AIM: SUN), a designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces the appointment of Colorectal consultant surgeon John Griffith and Neurosurgeon Jake Timothy to its Clinical Advisory Board ('CAB') with immediate effect.


John Griffith, BM, BS, FRCS, is a Consultant Colorectal and General Surgeon specialising in colorectal surgery including inflammatory bowel disease and functional disorders, as well as laparoscopic general surgical procedures including cholecystectomy and hernia operations. He graduated from the University of Nottingham in 1985 and completed his higher surgical training under the tutelage of some of the country's leading laparoscopic surgeons. John was awarded the status of National Trainer in laparoscopic colorectal surgery in 2008. Since this point he has performed the second highest number of training episodes on the LAPCO programme. As a dedicated trainer in his field he often runs training courses in colorectal and hernia surgery and is one of the faculties of LAPCO Training. He is also the national clinical adviser for colorectal cancer to NHS improvements and has pioneered survivorship work both at a local and national level. John is keen to work with the SI design team to develop and advance the current products further to the particular needs of colorectal surgery.

Jake Timothy, MBBS, MD, FRCS (Eng & SN), is a Consultant Neurosurgeon and Spine Surgeon specialising in the management of head trauma and the development of spinal surgery at Leeds General Infirmary. Trained at Charing Cross and Westminster Medical School he moved up to Leeds in 1996. He developed a head injury clinic with links to secondary care and charitable organisations and organised several national conferences concerning Neurotrauma, both independently and in conjunction with Trauma Audit and Research Network (TARN). Jake was a National Institute of Clinical Excellence (NICE) advisor on interspinous process distracters (X-stop) and minimally invasive XLIF procedure and an international figure regarding the training of surgeons. He has introduced many new techniques to the department with a focus on MIS.

Graham Bowland, Chief Executive Officer for Surgical Innovation, said: "We are delighted to welcome both John and Jake to the CAB.  John's expertise in colorectal surgery will help us increase our awareness in this area and he is already liaising closely with our design team to develop new technologies for this specialism. Jake will be the first spinal surgeon to join SI's CAB and reinforces our strategy to transfer our technology into new areas of the body. Our CAB now consists of 11 extremely experienced surgeons with differing fields of speciality allowing SI to develop products to suit a broad range of clinical disciplines."



- ENDS -




Surgical Innovations Group plc

Doug Liversidge, Non-Executive Chairman

Tel: +44 (0) 113 230 7597

Graham Bowland, Chief Executive Officer



Seymour Pierce Limited

Mark Percy (Corporate Finance)

Tel: +44 (0) 20 7107 8000

David Banks (Corporate Broking)




Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780

Paul McManus

Mob: 07980 541 893 or

Lianne Cawthorne

Mob: 07584 391 303 or


Notes to Editors:


About Surgical Innovations Group plc


Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. 


As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.


Over 120 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.


The Group's patented products are sold through three main channels:


SI brand

Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent. 


OEM and IP

The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion. 




SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime. 


For more information, see


This information is provided by RNS
The company news service from the London Stock Exchange
UK 100

Latest directors dealings